3 Biden Healthcare Stocks to Watch
The administration's focus on the Affordable Care Act, access to healthcare, and research may accelerate growth for these three stocks.
Illumina(ILMN)
Nasdaq Global Select
ILMN
$398.39
-$5.79
-1.4%
Price as of April 20, 2021, 4:00 p.m. ET
View Interactive ILMN Charts
The company develops, manufactures, and markets next-generation life-science tools and integrated systems to analyze genetic variations and biological functions.
Interactive Chart
News & Analysis: Illumina
The Fool has written over 500 articles on Illumina.
Is Illumina Still a Buy Without the GRAIL Acquisition?
Sometimes the most carefully laid plans hit unforeseen snags.
The Big Questions for Illumina After Its Q1 Sneak Peek and 2021 Guidance
The gene sequencing giant has a couple of key challenges going forward.
This Unstoppable Stock Doesn't Pay a Dividend Yet, but It Could
This giant of the genomic revolution ticks nearly all the boxes dividend investors should look for.
Could Illumina's Quest to Acquire GRAIL Fail?
The chances are certainly higher now that the deal won't happen.
Why Illumina Stock Fell 12.6% in March
The biotech was under pressure last month, but it's bouncing back in April.
Why Illumina Stock Just Jumped 10%
The DNA sequencing company is gearing up to report a big beat later this month.
Is Illumina Still a Good Stock to Buy?
The company's attempts to grow through acquisition keep running into problems.
Buy These 3 Stocks to Cash In on the Genomics Revolution
Gene science will continue to drive the healthcare sector to new heights.
These 3 Tech Stocks Are Building the Future
For long-term investors, the recent tech sell-off has discounted the following companies building the crucial technology platforms of tomorrow.
